Cholesterol toxicity may damage pancreatic β-cells, leading to decreased insulin secretion and impaired glucose tolerance (pages 340–347).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Semenkovich, C.F. J.Clin. Invest. 116, 1813–1822 (2006).
Brunham, L.R. et al. Nat. Med. 13, 340–347 (2007).
Prentki, M. & Nolan, C.J. J. Clin. Invest. 116, 1802–1812 (2006).
Brewer, H.B. N. Engl. J. Med. 350, 1491–1494 (2004).
Rust, S. et al. Nat. Genet. 22, 352–355 (1999).
Rhodes, C.J. Science 307, 380–384 (2005).
Butler, A.E. Diabetes 52, 102–110 (2003).
Van Citters, G.W. et al. J. Clin. Endocrinol. Metab. 87, 5191–5198 (2002).
Haghpassand, M. et al. J. Clin. Invest. 108, 1315–1320 (2001).
Van Eck, M. et al. Arterioscler. Thromb. Vasc. Biol. 26, 929–934 (2006).
Chawla, A. et al. Science 294, 1866–1870 (2001).
Wente, W. et al. Endocrinology, published online 28 December 2006 (doi:10.1210/en.2006-1247).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Chakravarthy, M., Semenkovich, C. The ABCs of β-cell dysfunction in type 2 diabetes. Nat Med 13, 241–242 (2007). https://doi.org/10.1038/nm0307-241
Issue Date:
DOI: https://doi.org/10.1038/nm0307-241